{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:16:32Z","timestamp":1787166992543,"version":"build-2736575974"},"reference-count":101,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ad.2017.09.014","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T11:01:40Z","timestamp":1517482900000},"page":"303-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Psoriasis asociada al VIH"],"prefix":"10.1016","volume":"109","author":[{"given":"N.","family":"Queir\u00f3s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2017.09.014_bib0510","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1097\/QAD.0b013e328362e832","article-title":"Dramatic increases in HIV prevalence after scale-up of antiretroviral treatment: A longitudinal population-based HIV surveillance study in rural KwaZulu-Natal","volume":"27","author":"Zaidi","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.ad.2017.09.014_bib0515","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/108729100317696","article-title":"HIV-associated psoriasis","volume":"14","author":"Mallon","year":"2000","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.ad.2017.09.014_bib0520","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-4362.1996.tb01658.x","article-title":"Psoriasis and HIV infection","volume":"35","author":"Montazeri","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0525","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1258\/ijsa.2011.010525","article-title":"Particular clinical presentations of psoriasis in HIV patients","volume":"22","author":"Fernandes","year":"2011","journal-title":"Int J STD AIDS"},{"issue":"Suppl 2","key":"10.1016\/j.ad.2017.09.014_bib0530","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1468-3083.2011.04410.x","article-title":"The concept of psoriasis as a systemic inflammation: Implications for disease management","volume":"26","author":"Reich","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2017.09.014_bib0535","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2133.2006.07405.x","article-title":"European patient perspectives on the impact of psoriasis: The EUROPSO patient membership survey","volume":"155","author":"Dubertret","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0540","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1517\/13543784.9.7.1511","article-title":"Psoriatic arthritis","volume":"9","author":"Gladman","year":"2000","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ad.2017.09.014_bib0545","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaad.2009.05.047","article-title":"Latitude and psoriasis prevalence","volume":"65","author":"Jacobson","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0550","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease concomitance in psoriasis","volume":"32","author":"Henseler","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0555","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/exd.12192","article-title":"Genetic control of psoriasis is relatively distinct from that of metabolic syndrome and coronary artery disease","volume":"22","author":"Gupta","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0560","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12016-007-0039-2","article-title":"Immunopathogenesis of psoriasis","volume":"33","author":"Nickoloff","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.ad.2017.09.014_bib0565","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1600-0625.2007.00629.x","article-title":"Immunopathogenesis of psoriasis","volume":"16","author":"Sabat","year":"2007","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0570","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/jid.2008.225","article-title":"Resident and \u201cinflammatory\u201d dendritic cells in human skin","volume":"129","author":"Zaba","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0575","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1084\/jem.20080129","article-title":"Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment","volume":"206","author":"Albanesi","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.ad.2017.09.014_bib0580","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1084\/jem.20090480","article-title":"Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8","volume":"206","author":"Ganguly","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.ad.2017.09.014_bib0585","doi-asserted-by":"crossref","first-page":"73ra19","DOI":"10.1126\/scitranslmed.3001180","article-title":"Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus","volume":"3","author":"Lande","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ad.2017.09.014_bib0590","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.ad.2017.09.014_bib0595","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0509736102","article-title":"Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)","volume":"102","author":"Lowes","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ad.2017.09.014_bib0600","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.ad.2017.09.014_bib0605","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.it.2012.11.005","article-title":"The IL-23\/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses","volume":"34","author":"Lowes","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1016\/j.ad.2017.09.014_bib0610","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1189\/JLB.0109046","article-title":"IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines","volume":"86","author":"Ortega","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ad.2017.09.014_bib0615","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation","volume":"35","author":"Cai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.ad.2017.09.014_bib0620","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.4049\/jimmunol.1100804","article-title":"Identification of a novel pro-inflammatory human skin-homing Vc9Vd2 T cell subset with a potential role in psoriasis","volume":"187","author":"Laggner","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.ad.2017.09.014_bib0625","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.4049\/jimmunol.0900036","article-title":"IL-23 drives pathogenic IL-17-producing CD8+ T cells","volume":"182","author":"Ciric","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.ad.2017.09.014_bib0630","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1038\/jid.2014.216","article-title":"A new player on the psoriasis block: IL-17A- and IL-22-producing innate lymphoid cells","volume":"134","author":"Ward","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0635","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1038\/jid.2014.146","article-title":"Composition of innate lymphoid cell subsets in the human skin: Enrichment of NCR+ ILC3 in lesional skin and blood of psoriasis patients","volume":"134","author":"Teunissen","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0640","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/jid.2013.526","article-title":"In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing ROR\u03b3t and IL-17","volume":"134","author":"Keijsers","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0645","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4049\/jimmunol.1100123","article-title":"Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis","volume":"187","author":"Lin","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.ad.2017.09.014_bib0650","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/nm.1995","article-title":"Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis","volume":"15","author":"Caruso","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.ad.2017.09.014_bib0655","doi-asserted-by":"crossref","first-page":"e51752","DOI":"10.1371\/journal.pone.0051752","article-title":"Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis","volume":"8","author":"Singh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ad.2017.09.014_bib0660","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ad.2017.09.014_bib0665","doi-asserted-by":"crossref","first-page":"a006841","DOI":"10.1101\/cshperspect.a006841","article-title":"Origins of HIV and the AIDS pandemic","volume":"1","author":"Sharp","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ad.2017.09.014_bib0670","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12274","article-title":"HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration","volume":"498","author":"Cooper","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ad.2017.09.014_bib0675","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2217\/bmm.11.15","article-title":"Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection","volume":"5","author":"Lichtfuss","year":"2011","journal-title":"Biomark Med"},{"key":"10.1016\/j.ad.2017.09.014_bib0680","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/nm.2004","article-title":"Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1","volume":"15","author":"Meier","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.ad.2017.09.014_bib0685","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ad.2017.09.014_bib0690","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1097\/QAD.0b013e3280108704","article-title":"Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses","volume":"20","author":"Hsue","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.ad.2017.09.014_bib0695","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/QAD.0b013e3283344895","article-title":"HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells","volume":"24","author":"Prendergast","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.ad.2017.09.014_bib0700","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/cid\/cir627","article-title":"Premature age-related comorbidities among HIV-infected persons compared with the general population","volume":"53","author":"Guaraldi","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ad.2017.09.014_bib0705","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/cid\/ciu701","article-title":"Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: The AGEhIV cohort study","volume":"59","author":"Schouten","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ad.2017.09.014_bib0710","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1097\/QAD.0b013e32833ef7bb","article-title":"Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV positive adults on suppressive antiretroviral therapy","volume":"24","author":"Yukl","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.ad.2017.09.014_bib0715","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ad.2017.09.014_bib0720","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0140-6736(14)60164-1","article-title":"HIV infection: Epidemiology, pathogenesis, treatment, and prevention","volume":"384","author":"Maartens","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ad.2017.09.014_bib0725","first-page":"59","article-title":"Cardiac disease associated with human immunodeficiency virus infection","volume":"35","author":"Bloomfield","year":"2017","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.ad.2017.09.014_bib0730","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(08)60423-7","article-title":"Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV infected patients enrolled in the D:A:D study: A multi-cohort collaboration","volume":"371","author":"Sabin","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ad.2017.09.014_bib0735","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antirretroviral drugs and the risk of myocardial infarction","volume":"356","author":"Friis-M\u00f8ller","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2017.09.014_bib0740","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/MED.0b013e32833dde87","article-title":"HIV protease inhibitors and obesity","volume":"17","author":"Anuurad","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.ad.2017.09.014_bib0745","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/ncpcardio1437","article-title":"Cardiac manifestations of HIV infection: An African perspective","volume":"6","author":"Ntsekhe","year":"2009","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.ad.2017.09.014_bib0750","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0001-7310(08)74955-X","article-title":"Psoriasis and HIV infection","volume":"99","author":"Leal","year":"2008","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2017.09.014_bib0755","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/QAI.0000000000001431","article-title":"HIV infection increases the risk of incident psoriasis","volume":"75","author":"Yen","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ad.2017.09.014_bib0760","doi-asserted-by":"crossref","first-page":"e1002514","DOI":"10.1371\/journal.pgen.1002514","article-title":"Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease","volume":"8","author":"Chen","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1016\/j.ad.2017.09.014_bib0765","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1093\/hmg\/ddr215","article-title":"Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesis","volume":"20","author":"Bijlmakers","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ad.2017.09.014_bib0770","doi-asserted-by":"crossref","first-page":"36592","DOI":"10.1074\/jbc.M111.283762","article-title":"ABIN1 protein cooperates with TAX1BP1 and A20 proteins to inhibit antiviral signaling","volume":"286","author":"Gao","year":"2011","journal-title":"J Biol Chem."},{"key":"10.1016\/j.ad.2017.09.014_bib0775","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ng.694","article-title":"Genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1","volume":"42","author":"Strange","year":"2010","journal-title":"Nat Genet."},{"key":"10.1016\/j.ad.2017.09.014_bib0780","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1038\/jid.2010.214","article-title":"Carriers of rare missense variants in IFIH1 are protected from psoriasis","volume":"130","author":"Li","year":"2010","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.ad.2017.09.014_bib0785","first-page":"372","article-title":"Examining HIV viral load in a matched cohort of HIV positive individuals with and without psoriasis","volume":"16","author":"Wu","year":"2017","journal-title":"J Drugs Dermatol."},{"key":"10.1016\/j.ad.2017.09.014_bib0790","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.humimm.2016.10.018","article-title":"Psoriasis risk SNPs and their association with HIV-1 control","volume":"78","author":"Nititham","year":"2017","journal-title":"Hum Immunol."},{"key":"10.1016\/j.ad.2017.09.014_bib0795","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/archderm.1987.01660360050012","article-title":"Acquired immunodeficiency syndrome-associated psoriasis and reactive arthritis","volume":"123","author":"Duvic","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0800","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D34SF63339","article-title":"Unraveling the paradoxes of HIV-associated psoriasis: A review of T-cell subsets and cytokine profiles","volume":"13","author":"Fife","year":"2007","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.ad.2017.09.014_bib0805","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S1473-3099(10)70101-8","article-title":"HIV-associated psoriasis: Pathogenesis, clinical features, and management","volume":"10","author":"Morar","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ad.2017.09.014_bib0810","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1006\/bbrc.1994.1557","article-title":"Identification of an HIV-1 Nef peptide that binds to HLA class ii antigens","volume":"200","author":"Torres","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ad.2017.09.014_bib0815","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1586\/eri.11.21","article-title":"Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy","volume":"9","author":"Lawn","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ad.2017.09.014_bib0820","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.jaad.2014.09.032","article-title":"Psoriasis as a manifestation of HIV-related immune reconstitution inflammatory syndrome","volume":"72","author":"Tripathi","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0825","first-page":"1","article-title":"Dermatological management of human immunodeficiency virus","volume":"12","author":"Bartlett","year":"2007","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.ad.2017.09.014_bib0830","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ad.2017.09.014_bib0835","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0002-9394(14)74064-4","article-title":"Bilateral panuveitis, sebopsoriasis, and secondary syphilis in a patient with acquired immunodeficiency syndrome","volume":"114","author":"Pillai","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ad.2017.09.014_bib0840","first-page":"125","article-title":"Treatment of sebopsoriasis\u2014A clinical trial: An etiological approach","volume":"169","author":"Doring","year":"1984","journal-title":"Dermatologica"},{"key":"10.1016\/j.ad.2017.09.014_bib0845","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1111\/1346-8138.13850","article-title":"Occult HIV infection in Japanese rupioid psoriasis","volume":"44","author":"Itoi-Ochi","year":"2017","journal-title":"J Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0850","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/archderm.1991.01680090113015","article-title":"Cutaneous manifestations of human immunodeficiency virus infection. Part II","volume":"14","author":"Dover","year":"1991","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.ad.2017.09.014_bib0855","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1758-2652-14-5","article-title":"New insights into HIV-1-primary skin disorders","volume":"14","author":"Cedeno-Laurent","year":"2011","journal-title":"J Int AIDS Soc."},{"key":"10.1016\/j.ad.2017.09.014_bib0860","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0889-857X(21)00086-7","article-title":"Reactive arthritis and associated arthritides","volume":"17","author":"Keat","year":"1991","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.ad.2017.09.014_bib0865","first-page":"1043","article-title":"Psoriasis and HIV: Rupioid psoriasis, an uncommon presentation","volume":"3","author":"Mendoza","year":"2015","journal-title":"J Dermatolog Clin Res"},{"key":"10.1016\/j.ad.2017.09.014_bib0870","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00296-013-2876-z","article-title":"High prevalence of psoriatic arthritis in dermatological patients with psoriasis: A cross-sectional study","volume":"34","author":"Henes","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ad.2017.09.014_bib0875","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000083509","article-title":"The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis","volume":"210","author":"Schmitt","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2017.09.014_bib0880","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/11530070-000000000-00000","article-title":"Pityriasis rubra pilaris: A review of diagnosis and treatment","volume":"11","author":"Klein","year":"2010","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0885","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/000155599750011426","article-title":"Cutaneous T-cell lymphoma and human immunodeficiency virus infection: 2 cases and a review of the literature","volume":"79","author":"Mu\u00f1oz-P\u00e9rez","year":"1999","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.ad.2017.09.014_bib0890","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000346242","article-title":"HIV-related CD8+ cutaneous pseudolymphoma: Efficacy of methotrexate","volume":"226","author":"Ingen-Housz-Oro","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2017.09.014_bib0895","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ad.2011.08.013","article-title":"Infiltraci\u00f3n cut\u00e1nea por linfocitos T CD8+ asociada a virus de la inmunodeficiencia humana","volume":"103","author":"Fern\u00e1ndez-Morano","year":"2012","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2017.09.014_bib0900","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00007611-199403000-00011","article-title":"Crusted (Norwegian) scabies in patients with AIDS: The range of clinical presentations","volume":"87","author":"Schlesinger","year":"1994","journal-title":"South Med J"},{"key":"10.1016\/j.ad.2017.09.014_bib0905","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jaad.2009.03.047","article-title":"Psoriasis in patients with HIV infection: From the Medical Board of the National Psoriasis Foundation","volume":"62","author":"Menon","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0910","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jaad.2005.12.030","article-title":"Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: An institutional urban clinic experience","volume":"54","author":"Zancanaro","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0915","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/1523-1747.ep12464137","article-title":"Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment","volume":"91","author":"Stern","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0920","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1067\/mjd.2001.114576","article-title":"The risk of melanoma in association with long-term exposure to PUVA","volume":"44","author":"Stern","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0925","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/00365540500322296","article-title":"Clinical improvement of psoriasis in an AIDS patient effectively treated with combination antiretroviral therapy","volume":"38","author":"Vittorio Luigi de Socio","year":"2006","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ad.2017.09.014_bib0930","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1473-3099(07)70161-5","article-title":"HIV-associated psoriasis","volume":"7","author":"Mamkin","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ad.2017.09.014_bib0935","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000345762","article-title":"Complete resolution of erythrodermic psoriasis in an HIV and HCV patient unresponsive to antipsoriatic treatments after highly active antiretroviral therapy (ritonavir, atazanavir, emtricitabine, tenofovir)","volume":"225","author":"Chiricozzi","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2017.09.014_bib0940","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2165\/00002018-200326090-00002","article-title":"Hydroxyurea in the treatment of HIV infection: Clinical efficacy and safety concerns","volume":"26","author":"Lisziewicz","year":"2003","journal-title":"Drug Saf"},{"key":"10.1016\/j.ad.2017.09.014_bib0945","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/archderm.1997.03890420043005","article-title":"Acitretin therapy is effective for psoriasis associated with human immunodeficiency virus infection","volume":"133","author":"Buccheri","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0950","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/0140-6736(92)90852-T","article-title":"Use of cyclosporin for psoriasis in HIV-positive patient","volume":"339","author":"Allen","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ad.2017.09.014_bib0955","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0190-9622(97)70160-9","article-title":"Alleviation of HIV-associated psoriasis and psoriatic arthritis with cyclosporine","volume":"37","author":"Tourne","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0960","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/247553031117a00302","article-title":"Hydroxyurea for the treatment of psoriasis including in HIV-infected individuals: A review","volume":"17","author":"Lee","year":"2011","journal-title":"Psoriasis Forum"},{"key":"10.1016\/j.ad.2017.09.014_bib0965","article-title":"Apremilast: A novel oral treatment for psoriasis and psoriatic arthritis","author":"Torres","year":"2017","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.ad.2017.09.014_bib0970","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1111\/jdv.14301","article-title":"Apremilast for a psoriasis patient with HIV and hepatitis C","volume":"31","author":"Reddy","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 1","key":"10.1016\/j.ad.2017.09.014_bib0975","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0001-7310(10)70013-2","article-title":"Treatment of moderate-severe psoriasis with etanercept in patients with chronic human immunodeficiency virus infection","volume":"101","author":"Barco","year":"2010","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2017.09.014_bib0980","first-page":"1353","article-title":"Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection","volume":"34","author":"Linardaki","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0985","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jaad.2015.11.043","article-title":"Use of tumor necrosis factor (TNF) inhibitors in patients with HIV\/AIDS","volume":"74","author":"Gallitano","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2017.09.014_bib0990","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1006\/cyto.1996.0099","article-title":"Ligand passing by the p75 tumour necrosis factor receptor enhances HIV-1 activation","volume":"8","author":"Butera","year":"1996","journal-title":"Cytokine"},{"key":"10.1016\/j.ad.2017.09.014_bib0995","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.autrev.2008.05.002","article-title":"Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases","volume":"8","author":"Cavazzana","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ad.2017.09.014_bib1000","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3109\/09546634.2011.579085","article-title":"Ustekinumab for the treatment of HIV psoriasis","volume":"23","author":"Paparizos","year":"2012","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.ad.2017.09.014_bib1005","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/jdv.12531","article-title":"Successful treatment of ustekinumab in a severe psoriasis patient with human immunodeficiency virus infection","volume":"29","author":"Saeki","year":"2015","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2017.09.014_bib1010","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2340\/00015555-2698","article-title":"Biologic therapies in HIV-infected patients with psoriasis: An Italian experience","volume":"97","author":"Bardazzi","year":"2017","journal-title":"Acta Derm Venereol"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731017305951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731017305951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:07:46Z","timestamp":1757552866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731017305951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":101,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0001731017305951"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2017.09.014","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoriasis asociada al VIH","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2017.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 AEDV. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}